Antibody Response to the Furin Cleavable Twenty-Seven Amino Acid Peptide (p27) of the Fusion Protein in Respiratory Syncytial Virus (RSV) Infected Adult Hematopoietic Cell Transplant (HCT) Recipients

被引:10
作者
Ye, Xunyan [1 ]
Cabral de Rezende, Wanderson [2 ]
Iwuchukwu, Obinna Patrick [1 ]
Avadhanula, Vasanthi [1 ]
Ferlic-Stark, Laura L. [1 ]
Patel, Kirtida D. [1 ]
Piedra, Felipe-Andres [1 ]
Shah, Dimpy P. [3 ]
Chemaly, Roy F. [4 ,5 ,6 ]
Piedra, Pedro A. [1 ,2 ,7 ]
机构
[1] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA
[3] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Infect Control, Houston, TX 77030 USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Employee Hlth, Houston, TX 77030 USA
[7] Baylor Coll Med, Dept Pediat, Houston, TX 77003 USA
关键词
respiratory syncytial virus; p27; antibody; hematopoietic cell transplant recipients; HOSPITALIZATIONS; PALIVIZUMAB; PREVENTION; MANAGEMENT; ACTIVATION; CHILDREN; INFANTS;
D O I
10.3390/vaccines8020192
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background:Cleavage of the inactive precursor fusion protein (F0) of respiratory syncytial virus (RSV) at two furin-recognition sites is required for membrane fusion activity, and the cleavage releases the twenty-seven amino acid peptide (p27). However, a recent study shows that p27 was an immunodominant epitope in RSV infected children, indicating that p27 was recognized as an immunogen. In the present study, we investigated the immunogenicity of p27 in an immunocompromised population of adults by measuring serum and mucosal antibody responses to p27 in samples from adult hematopoietic cell transplant (HCT) recipients.Methods:We prospectively enrolled a cohort of RSV infected HCT recipients. Serum and nasal-wash samples were obtained within the first week of RSV infection (acute) and 3 to 5 weeks post-infection (convalescent). We quantified the serum and mucosal IgG and IgA anti-p27 antibodies by a RSV/A p27 peptide enzyme-linked immunosorbent assay (ELISA) and serum and mucosal p27 like antibodies (P(27)LA) by a p27 competitive antibody (P(27)CA) assay.Results:The lower limit of detection for the ELISA and P(27)CA assays was 0.2 and 50 ng/mL, respectively with no cross-reaction detected with a panel of monoclonal antibodies targeting pre-fusion and post-fusion antigenic sites. P27 antibodies were detected at nanogram concentration in sera and nasal washes in the majority of RSV infected HCT recipients. However, there was no significant difference in the geometric mean antibody concentrations between the acute and convalescent sera (except for serum P(27)LA), between HCT recipients who shed RSV <14 days and >= 14 days, as well as between RSV/A and RSV/B infected HCT recipients. In addition, approximately 30% of HCT recipients had a 4-fold or greater decrease in mucosal IgG and IgA anti-p27 antibodies during viral clearance.Conclusion:In conclusion, in RSV naturally infected adult HCT recipients, the antibodies against p27 were detectable in both serum and nasal wash samples with higher concentration in serum than that in nasal washes. However, nearly 30% of RSV infected HCT recipients had a significant decrease in their mucosal anti-p27 antibody, suggesting that IgG and IgA anti-p27 antibodies were binding to either free viruses or RSV infected cells containing p27, and that anti-p27 antibodies in the respiratory tract were part of the mucosal antibody response in controlling RSV infection.
引用
收藏
页数:13
相关论文
共 29 条
[11]   Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion [J].
González-Reyes, L ;
Ruiz-Argüello, MB ;
García-Barreno, B ;
Calder, L ;
López, JA ;
Albar, JP ;
Skehel, JJ ;
Wiley, DC ;
Melero, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (17) :9859-9864
[12]   Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B [J].
Hause, Anne M. ;
Henke, David M. ;
Avadhanula, Vasanthi ;
Shaw, Chad A. ;
Tapia, Lorena I. ;
Piedra, Pedro A. .
PLOS ONE, 2017, 12 (04)
[13]   Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus [J].
Johnson, S ;
Oliver, C ;
Prince, GA ;
Hemming, VG ;
Pfarr, DS ;
Wang, SC ;
Dormitzer, M ;
OGrady, J ;
Koenig, S ;
Tamura, JK ;
Woods, R ;
Bansal, G ;
Couchenour, D ;
Tsao, E ;
Hall, WC ;
Young, JF .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (05) :1215-1224
[14]  
joint statement with the Fetus and Newborn Committee, 1999, Paediatr Child Health, V4, P474
[15]   Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Factors Determining Progression to Lower Respiratory Tract Disease [J].
Kim, Yae-Jean ;
Guthrie, Katherine A. ;
Waghmare, Alpana ;
Walsh, Edward E. ;
Falsey, Ann R. ;
Kuypers, Jane ;
Cent, Anne ;
Englund, Janet A. ;
Boeckh, Michael .
JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (08) :1195-1204
[16]   A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism [J].
Krarup, Anders ;
Truan, Daphne ;
Furmanova-Hollenstein, Polina ;
Bogaert, Lies ;
Bouchier, Pascale ;
Bisschop, Ilona J. M. ;
Widjojoatmodjo, Myra N. ;
Zahn, Roland ;
Schuitemaker, Hanneke ;
McLellan, Jason S. ;
Langedijk, Johannes P. M. .
NATURE COMMUNICATIONS, 2015, 6
[17]   High Morbidity and Mortality in Adults Hospitalized for Respiratory Syncytial Virus Infections [J].
Lee, N. ;
Lui, G. C. Y. ;
Wong, K. T. ;
Li, T. C. M. ;
Tse, E. C. M. ;
Chan, J. Y. C. ;
Yu, J. ;
Wong, S. S. M. ;
Choi, K. W. ;
Wong, R. Y. K. ;
Ngai, K. L. K. ;
Hui, D. S. C. ;
Chan, P. K. S. .
CLINICAL INFECTIOUS DISEASES, 2013, 57 (08) :1069-1077
[18]   Removal of the N-Glycosylation Sequon at Position N116 Located in p27 of the Respiratory Syncytial Virus Fusion Protein Elicits Enhanced Antibody Responses after DNA Immunization [J].
Leemans, Annelies ;
Boeren, Marlies ;
Van der Gucht, Winke ;
Pintelon, Isabel ;
Roose, Kenny ;
Schepens, Bert ;
Saelens, Xavier ;
Bailey, Dalan ;
Martinet, Wim ;
Caljon, Guy ;
Maes, Louis ;
Cos, Paul ;
Delputte, Peter .
VIRUSES-BASEL, 2018, 10 (08)
[19]   Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit [J].
Lehners, N. ;
Schnitzler, P. ;
Geis, S. ;
Puthenparambil, J. ;
Benz, M. A. ;
Alber, B. ;
Luft, T. ;
Dreger, P. ;
Eisenbach, C. ;
Kunz, C. ;
Benner, A. ;
Buchholz, U. ;
Aichinger, E. ;
Frank, U. ;
Heeg, K. ;
Ho, A. D. ;
Egerer, G. .
BONE MARROW TRANSPLANTATION, 2013, 48 (12) :1548-1553
[20]   Diagnosis and management of bronchiolitis [J].
Lieberthal, Allan S. ;
Bauchner, Howard ;
Hall, Caroline B. ;
Johnson, David W. ;
Kotagal, Uma ;
Light, Michael J. ;
Mason, Wilbert ;
Meissner, H. Cody ;
Phelan, Kieran J. ;
Zorc, Joseph J. ;
Brown, Mark A. ;
Clover, Richard D. ;
Nathanson, Ian T. ;
Korppi, Matti ;
Shiffman, Richard N. ;
Stanko-Lopp, Danette ;
Davidson, Caryn .
PEDIATRICS, 2006, 118 (04) :1774-1793